Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.
Related Research units
Abstract
This study was aimed at detecting and characterizing circulating tumor cells (CTC) before and after neoadjuvant therapy (NT) in the peripheral blood of patients with breast cancer.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 9 |
| ISSN | 1078-0432 |
| Publication status | Published - 2010 |
| pubmed | 20406831 |
|---|
